Renata PLC 2021 AR2
The report outlines the financial and operational performance of Renata Limited and its subsidiaries for the fiscal year ended June 30, 2021. Despite the challenges of the COVID-19 pandemic, the company achieved a 21.1% growth in net sales and a 23.4% increase in net profit, largely driven by its contract-manufacturing segment. Renata continued to expand its product portfolio, introducing 47 new formulations, and maintained its market-leading position in the animal health sector. Additionally, the company demonstrated its commitment to corporate social responsibility through significant contributions to COVID-19 treatment facilities, employee healthcare, and community support.
Company: Renata PLC
Sector: Manufacturing
Country: Bangladesh
Year: 2021
Type: AR2
Pages: 201
Renata PLC
The report outlines the financial and operational performance of Renata Limited and its subsidiaries for the fiscal year ended June 30, 2021. Despite the challenges of the COVID-19 pandemic, the company achieved a 21.1% growth in net sales and a 23.4% increase in net profit, largely driven by its contract-manufacturing segment. Renata continued to expand its product portfolio, introducing 47 new formulations, and maintained its market-leading position in the animal health sector. Additionally, the company demonstrated its commitment to corporate social responsibility through significant contributions to COVID-19 treatment facilities, employee healthcare, and community support.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jul 1, 2020 - Jun 30, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees